Prosecution Insights
Prosecution Insights
31 pending office actions • 23 art units • 31 examiners • 0 of 31 (0%) have an AI response strategy ready • 34 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (13%) |
| §101 + other | 3 (10%) |
| §103 only | 5 (16%) |
| §102 only | 2 (6%) |
| §112 only | 4 (13%) |
| Double-patenting only | 1 (3%) |
| Double-patenting + other | 1 (3%) |
| Multi-statute (no §101) | 10 (32%) |
| No statute on record | 1 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUSSAINI, ATTIYA SAYYADA | 1 | 56.1% | +13.9% |
| HELCO, NICHOLAS JOHN | 1 | 69.6% | +42.9% |
| HOLLAND, PAUL J | 1 | 57.3% | +64.7% |
| BARR, MARY EVANGELINE | 1 | 35.9% | +31.8% |
| LIPPERT, JOHN WILLIAM | 1 | 56.6% | +41.3% |
| FOLEY, SHANON A | 1 | 73.2% | +18.0% |
| SU-TOBON, QIWEN NMN | 1 | 75.0% | +100.0% |
| VAJDA, KRISTIN ANN | 1 | 84.0% | +10.9% |
| REICHERT, RACHELLE LEIGH | 1 | 30.0% | +33.7% |
| STRIEGEL, THEODORE CHARLES | 1 | 20.0% | +20.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275287 | CULLIN-RING E3 UBIQUITIN LIGASE 4 INHIBITOR COMPOUNDS AND METHODS OF THEIR USE | VAJDA, KRISTIN ANN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261907 | SYSTEMS, METHODS, AND DEVICES, FOR IMPLEMENTING INTERVENTION TREATMENT REGIMENS FOR A POPULATION OF SUBJECTS | REICHERT, RACHELLE LEIGH | 12d |
| 17290128 | PEPTIDES, COMPOSITIONS AND VACCINES FOR TREATMENT OF MICROSATELLITE INSTABLITY HYPERMUTATED TUMORS AND METHODS OF USE THEREOF | FAUST, AMBER KATHLEEN | 21d |
| 17781929 | METHOD OF TREATMENT WITH KCNQ CHANNEL OPENERS | TRAN, ERIC | 22d |
| 18036095 | PHENOTHIAZINE COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AGE-RELATED AND NEUROLOGICAL DISEASES | COUGHLIN, MATTHEW P | 28d |
| 17633255 | METHOD OF TREATING KELOIDS | MIDDLETON, DANAYA L | 28d |
| 17606981 | Elucidating a Proteomic Signature for the Detection of Intracerebral Aneurysms | DUNN, MCKENZIE A | 54d |
| 18009017 | DETACHMENT MECHANISM FOR DETACHABLE-TIP ENDOVASCULAR DEVICES | KHANDKER, RAIHAN R | 62d |
| 18002075 | SYSTEMS AND METHODS FOR EVALUATING A SUBJECT FOR INFLAMMATORY BOWEL DISEASE MANAGEMENT | EDOUARD, JONATHAN CHRISTOPHER | 65d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18712863 | SYSTEMS AND METHODS FOR ELECTROCARDIOGRAM DEEP LEARNING INTERPRETABILITY | BARR, MARY EVANGELINE | 97d overdue |
| 18261907 | SYSTEMS, METHODS, AND DEVICES, FOR IMPLEMENTING INTERVENTION TREATMENT REGIMENS FOR A POPULATION OF SUBJECTS | REICHERT, RACHELLE LEIGH | 12d |
| 18866723 | Non-Invasive Intranasal Neuromodulation System | HUSSAINI, ATTIYA SAYYADA | — |
| 18918891 | SYSTEMS AND METHODS FOR IDENTIFYING PROSTATE CANCER PATIENTS AT HIGH-RISK OF PROGRESSION | HELCO, NICHOLAS JOHN | — |
| 18750693 | THERAPEUTIC ACID CERAMIDASE COMPOSITIONS AND METHODS OF MAKING AND USING THEM | HOLLAND, PAUL J | — |
| 18708774 | LIQUID RADIOEMBOLIC AGENTS AND RELATED EMBOLIZATION SYSTEMS AND METHODS OF EMBOLIZATION | LIPPERT, JOHN WILLIAM | — |
| 18556458 | CHIMERIC NEWCASTLE DISEASE VIRUS EXPRESSING APMV HN AND F PROTEINS | FOLEY, SHANON A | — |
| 18547930 | METHOD FOR DECREASING DEGENERATION OF RETINAL GANGLION CELLS | SU-TOBON, QIWEN NMN | — |
| Art Unit | Apps |
|---|---|
| 1671 | 2 |
| 3686 | 2 |
| 1674 | 2 |
| 1656 | 1 |
| 3682 | 1 |
| 1636 | 1 |
| 1622 | 1 |
| 1626 | 1 |
| 1628 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18866723 | Non-Invasive Intranasal Neuromodulation System | HUSSAINI, ATTIYA SAYYADA | — | §102§103 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18918891 | SYSTEMS AND METHODS FOR IDENTIFYING PROSTATE CANCER PATIENTS AT HIGH-RISK OF PROGRESSION | HELCO, NICHOLAS JOHN | — | §103 | Non-Final OA | — | Pending | Oct 17, 2024 |
| 18750693 | THERAPEUTIC ACID CERAMIDASE COMPOSITIONS AND METHODS OF MAKING AND USING THEM | HOLLAND, PAUL J | 1656 | §103 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18712863 | SYSTEMS AND METHODS FOR ELECTROCARDIOGRAM DEEP LEARNING INTERPRETABILITY | BARR, MARY EVANGELINE | 3682 | — | Final Rejection | 97d overdue | Pending | May 23, 2024 |
| 18708774 | LIQUID RADIOEMBOLIC AGENTS AND RELATED EMBOLIZATION SYSTEMS AND METHODS OF EMBOLIZATION | LIPPERT, JOHN WILLIAM | — | §102§103 | Non-Final OA | — | Pending | May 09, 2024 |
| 18556458 | CHIMERIC NEWCASTLE DISEASE VIRUS EXPRESSING APMV HN AND F PROTEINS | FOLEY, SHANON A | 1671 | §103§112 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18547930 | METHOD FOR DECREASING DEGENERATION OF RETINAL GANGLION CELLS | SU-TOBON, QIWEN NMN | 1636 | §112 | Final Rejection | — | Pending | Aug 25, 2023 |
| 18275287 | CULLIN-RING E3 UBIQUITIN LIGASE 4 INHIBITOR COMPOUNDS AND METHODS OF THEIR USE | VAJDA, KRISTIN ANN | 1622 | §102 | Non-Final OA | — | Pending | Aug 01, 2023 |
| 18261907 | SYSTEMS, METHODS, AND DEVICES, FOR IMPLEMENTING INTERVENTION TREATMENT REGIMENS FOR A POPULATION OF SUBJECTS | REICHERT, RACHELLE LEIGH | 3686 | §101 | Final Rejection | 12d | Pending | Jul 18, 2023 |
| 18255852 | Systems and Methods for Dynamic Raman Profiling of Biological Diseases and Disorders | STRIEGEL, THEODORE CHARLES | — | DP | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18036095 | PHENOTHIAZINE COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AGE-RELATED AND NEUROLOGICAL DISEASES | COUGHLIN, MATTHEW P | 1626 | §102§103§112 | Final Rejection | 28d | Pending | May 09, 2023 |
| 18251670 | CXCR1/CXCR2 INHIBITORS FOR USE IN TREATING MYELOFIBROSIS | SZNAIDMAN, MARCOS L | 1628 | §103 | Non-Final OA | 25d overdue | Pending | May 03, 2023 |
| 18034965 | METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS | WHITE, DAWANNA SHAR-DAY | 1627 | §103DP | Final Rejection | 98d overdue | Pending | May 02, 2023 |
| 18250206 | METHODS FOR IDENTIFYING AND TARGETING THE MOLECULAR SUBTYPES OF ALZHEIMER'S DISEASE | NGUYEN, PETER | — | §101§102§103§112 | Non-Final OA | — | Pending | Apr 22, 2023 |
| 18249999 | SARS-COV-2 ANTIBODIES AND USES THEREOF | BARRERA, IMMACULADA | 1671 | §112 | Non-Final OA | 28d | Pending | Apr 21, 2023 |
| 18030983 | COMPOSITIONS FOR TREATMENT ALOPECIA AREATA, BIOMARKERS FOR TREATMENT SUCCESS AND, METHODS OF USE THEREOF | DEBERRY, REGINA M | 1647 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18248138 | SYSTEMS AND METHODS FOR EXPOSOMIC CLINICAL APPLICATIONS | SIOZOPOULOS, CONSTANTINE B | 3686 | §101 | Final Rejection | — | Pending | Apr 06, 2023 |
| 18002075 | SYSTEMS AND METHODS FOR EVALUATING A SUBJECT FOR INFLAMMATORY BOWEL DISEASE MANAGEMENT | EDOUARD, JONATHAN CHRISTOPHER | 3683 | §101 | Final Rejection | 65d | Pending | Dec 16, 2022 |
| 18001516 | SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA | CHEN, PO-CHIH | 1621 | §102 | Final Rejection | 71d overdue | Pending | Dec 12, 2022 |
| 18009017 | DETACHMENT MECHANISM FOR DETACHABLE-TIP ENDOVASCULAR DEVICES | KHANDKER, RAIHAN R | 3771 | §103§112 | Non-Final OA | 62d | Pending | Dec 08, 2022 |
| 17802789 | VEGFR-3-ACTIVATING AGENTS AND ONCOLYTIC VIRUSES AND USES THEREOF FOR THE TREATMENT OF CANCER | TRAN, CHRISTINA L | 1637 | §103 | Final Rejection | — | Pending | Aug 26, 2022 |
| 17781929 | METHOD OF TREATMENT WITH KCNQ CHANNEL OPENERS | TRAN, ERIC | 1629 | §103§112 | Final Rejection | 22d | Pending | Jun 02, 2022 |
| 17731115 | Treatment of Mood and Anxiety Disorders | CHERNYSHEV, OLGA N | 1675 | §103§112 | Final Rejection | — | Pending | Apr 27, 2022 |
| 17769485 | SYSTEMS AND METHODS FOR DETECTING A DISEASE CONDITION | BICKHAM, DAWN MARIE | 1685 | §103 | Non-Final OA | — | Pending | Apr 15, 2022 |
| 17769486 | SYSTEMS AND METHODS FOR DETECTING A DISEASE CONDITION | WHALEY, PABLO S | 3619 | §112 | Non-Final OA | — | Pending | Apr 15, 2022 |
| 17753660 | COMPOSITIONS INCLUDING MOLECULES OF MODIFIED MRNA AND METHODS OF USING THE SAME | SINGH, ANOOP KUMAR | 1632 | §103§112 | Final Rejection | — | Pending | Mar 10, 2022 |
| 17633255 | METHOD OF TREATING KELOIDS | MIDDLETON, DANAYA L | 1674 | §102§103§112 | Final Rejection | 28d | Pending | Feb 07, 2022 |
| 17544388 | INJECTION PORT PROTECTOR | MARRISON, SAMUEL JOSEPH | 3783 | §102§103 | Non-Final OA | — | Pending | Dec 07, 2021 |
| 17606981 | Elucidating a Proteomic Signature for the Detection of Intracerebral Aneurysms | DUNN, MCKENZIE A | 1678 | §101 | Non-Final OA | 54d | Pending | Oct 27, 2021 |
| 17290128 | PEPTIDES, COMPOSITIONS AND VACCINES FOR TREATMENT OF MICROSATELLITE INSTABLITY HYPERMUTATED TUMORS AND METHODS OF USE THEREOF | FAUST, AMBER KATHLEEN | 1643 | §101§112 | Non-Final OA | 21d | Pending | Apr 29, 2021 |
| 17041006 | METHODS OF TREATING MINIMAL RESIDUAL CANCER | MCCOLLUM, ANDREA K | 1674 | §112 | Final Rejection | 18d overdue | Pending | Sep 24, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial